Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Coherus BioSciences Q1 Adj. EPS $(0.35) Up From $(0.48) YoY, Sales $7.60M Up From $2.31M YoY

Author: Benzinga Newsdesk | May 12, 2025 04:23pm
Coherus BioSciences (NASDAQ:CHRS) reported quarterly losses of $(0.35) per share. This is a 27.08 percent increase over losses of $(0.48) per share from the same period last year. The company reported $7.60 million in sales this quarter. This is a 229.25 percent increase over sales of $2.31 million the same period last year.

Posted In: CHRS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist